For more information please contact the Press Office:
Tel: +49 6221 387-8443
Tel: +49 6221 387-8726
Hinxton, 5 December 2011 UK invests £75 million in European research infrastructure to support knowledge-based economy EMBL's European Bioinformatics Institute (EMBL-EBI) and the BBSRC warmly welcome today’s announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills’ Large Facilities Capital Fund for the ELIXIR research infrastructure.
Grenoble, 13 October 2011 Intruder detected: raise the alarm! Scientists at EMBL Grenoble have discovered how a protein sounds the alarm when it detects viruses invading a cell. The study, published today in Cell, is a key development in our understanding of the innate immune response, shedding light on how cells rapidly respond to a wide range of viruses including influenza, rabies and hepatitis.
Heidelberg/Hinxton, 14 September 2011 Five countries and EMBL sign Memorandum of Understanding to make ELIXIR a reality Today marks an important step for ELIXIR, Europe’s emerging research infrastructure for life-science information, as EMBL and Denmark, Finland, the Netherlands, Sweden and the United Kingdom have signed a Memorandum of Understanding to catalyse the implementation and construction of ELIXIR, with more countries planning to join in the near future.
- Genome Web , 16 September 2011 'Five EU States, EMBL Commit to Funding Pan-European Bioinformatics Infrastructure '
- Science Business , 14 September 2011 'Boost for plan to set up pan-European infrastructure for life science data'
Heidelberg, 18 August 2011 Fishing games gone wrong When an egg cell is being formed, the cellular machinery which separates chromosomes is extremely imprecise at fishing them out of the cell’s interior, scientists at EMBL Heidelberg have discovered. The findings, published in Cell, could explain why errors in the number of chromosomes in the egg cell are the leading cause of miscarriages and severe congenital diseases like Down's syndrome, as well as causing female infertility.
Heidelberg, 7 August 2011 Live from the scene: biochemistry in action Researchers can now watch molecules move in living cells, literally millisecond by millisecond, thanks to a new microscope developed by scientists at EMBL Heidelberg. Published online today in Nature Biotechnology, the new technique provides insights into processes that were so far invisible.
Heidelberg, 21 July 2011 A hot species for cool structures A fungus that lives at extremely high temperatures could help understand structures within our own cells. Scientists at EMBL and Heidelberg University were the first to sequence and analyse the genome of a heat-loving fungus, and used that information to determine the long sought 3-dimensional structure of the inner ring of the nuclear pore.
Heidelberg, 5 July 2011 Obituary - Lennart Philipson Lennart Philipson, who served as EMBL’s second Director General, has passed away. Lennart headed EMBL for over a decade between 1982-93, a crucial time for molecular biology when different scientific disciplines in the life sciences were becoming increasingly interlinked.
Heidelberg, 20 April 2011 What's your gut type? Scientists at EMBL Heidelberg and collaborators have found that humans have 3 different gut types. The study, published today in Nature, also uncovers microbial genetic markers that are related to traits like age, gender and body-mass index. The findings could help diagnose and predict outcomes for diseases like colo-rectal cancer, and inform treatment.
- SWR 2 (Germany) , 21 November 2011 Typberatung für den Darm
- New York Times (USA) , 20 April 2011 "Bacteria Divide People Into 3 Types, Scientists Say"
- Not Exactly Rocket Science (Discover Blogs) , 20 April 2011 "Divided by language, united by gut bacteria – people have three common gut types"
- Radio 1 (Belgium) , 20 April 2011 "Kunnen we binnenkort onze levensstijl aanpassen aan ons darmtype"
- Sueddeutsche Zeitung (Germany) , 20 April 2011 "Ökosystem im Bauch"
- Los Angeles Times (USA) , 20 April 2011 'Gut microbes: What's your type?'
Heidelberg, 24 March 2011 Small code change, big effect Scientists at EMBL Heidelberg have developed a new method which enables researchers to label any protein of their choice with any of a wide variety of previously available compounds, in living cells, by introducing a single artificial amino acid.
Heidelberg, 20 March 2011 The informant: a jumping gene Scientists at EMBL Heidelberg have developed a new method for studying gene regulation, by employing a jumping gene as an informant. Called GROMIT, it allows scientists to also create mouse models for human diseases caused by chromosomal rearrangements, such as Down syndrome.
Heidelberg, 6 March 2011 Suggesting genes' friends, facebook-style Scientists at EMBL Heidelberg and the DKFZ have developed a new method that uncovers the combined effects of genes. Published online today in Nature Methods, it helps understand how different genes can amplify, cancel out or mask each others’ effects, and enables scientists to suggest genes that interfere with each other in much the same manner that facebook suggests friends.
Hamburg, 14 February 2011 Two in one Scientists from EMBL Hamburg reveal new insights into the workings of an enzyme from Mycobacterium tuberculosis, the bacterium that causes tuberculosis. The findings present new opportunities for developing organism-specific drugs, which target the pathogen but leave other microorganisms, which are beneficial to us, untouched.
- Hamburger Abendblatt (Germany) , 22 March 2011 "Tuberkulose-Bakterien gezielter bekämpfen"
Heidelberg / Hinxton, 9 February 2011 BBSRC and EMBL-EBI welcome UK funds earmarked for major bioscience data infrastructure project The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK’s Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today.
Heidelberg, 3 February 2011 Blood-clotting protein linked to cancer and septicaemia Scientists in a collaboration between EMBL Heidelberg and the University of Heidelberg Medical Centre have discovered how stressed cells boost the production of the key blood-clotting factor, thrombin. Their work, published today in Molecular Cell, shows how cancer cells may be taking advantage of this process, and opens new possibilities for fighting back against cancer and septicaemia.
Heidelberg, 2 February 2011 The human genome's breaking points Scientists at EMBL Heidelberg and collaborators have identified the genetic sequence of an unprecedented 28 000 structural variants (SVs) – large portions of the human genome which differ from one person to another. The work, published in Nature, could help find the genetic causes of some diseases and also begins to explain why certain parts of the human genome change more than others.
Policy regarding use
Press and Picture Releases
EMBL press and picture releases including photographs, graphics, movies and videos are copyrighted by EMBL. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made.